Coyle Financial Counsel’s Boston Scientific BSX Stock Holding History

Coyle Financial Counsel’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$219K	Sell	3,495 -65	-2%	-$5.2K	0.05%	105
2025 Q4	$339K	Sell	3,560 -469	-12%	-$46K	0.07%	84
2025 Q3	$393K	Buy	4,029 +858	+27%	+$88.9K	0.09%	72
2025 Q2	$341K	Buy	+3,171	New	+$321K	0.09%	68
2018 Q3	–	Sell	-60	Closed	-$2K	–	69
2018 Q2	$2K	Buy	+60	New	+$1.81K	﹤0.01%	275

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Coyle Financial Counsel's BSX Position: Q1 2026 in Review

Coyle Financial Counsel reduced its Boston Scientific (BSX) stake by 1.8% in Q1 2026, selling an estimated $5.2K and leaving 3,495 shares worth $219K. The position accounts for 0.05% of the portfolio, ranked #105.

Coyle Financial Counsel first reported a position in BSX in Q2 2018 and has held it in 5 quarters since. The position peaked at $393K in Q3 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Coyle Financial Counsel held 3,495 shares of Boston Scientific worth $219K as of Q1 2026.
Coyle Financial Counsel sold 65 Boston Scientific shares in Q1 2026, an estimated $5.2K.
Boston Scientific made up 0.05% of Coyle Financial Counsel's portfolio in Q1 2026, its #105 holding.
Coyle Financial Counsel first reported a position in Boston Scientific in Q2 2018 and has held it in 5 quarters since.
Coyle Financial Counsel's Boston Scientific position peaked at $393K in Q3 2025.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Coyle Financial Counsel's 13F filing for Q1 2026, filed 12 May 2026.